Skip to content

Company information lookup

PHARMAUST LIMITED (PAA)

To develop its own drug discovery intellectual property as well as providing highly specialised medicinal and synthetic chemistry services on a contract basis to clients.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PAA 0.010 11.11% 0.010 0.011 0.009 0.011 0.009 7,128,415

PHARMAUST LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PAA
Securities
Official Listing Date 5 October, 2001
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.pharmaust.com
Registered Office Address Suite 7, 29 The Avenue, NEDLANDS, WA, AUSTRALIA, 6009
Head Office Telephone 08 9386 4787
Head Office Fax 08 9389 1464
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Dr Roger Aston (Executive Chairman)
Mr Robert Bishop (Executive Director)
Prof. David Morris (Non Exec. Director)
Mr Sam Wright (Non Exec. Director)
Company Secretary Mr Sam Wright
Principal Activities To develop its own drug discovery intellectual property as well as providing highly specialised medicinal and synthetic chemistry services on a contract basis to clients.

PHARMAUST LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
24/10/2014   Initial Director's Interest Notice 3 PDF
24/10/2014   Results of Annual General Meeting 1 PDF
24/10/2014   AGM Shareholder Presentation 55 PDF
22/10/2014 asterix First Two Patients in Canine Clinical Trial Begin Treatment 2 PDF
21/10/2014 asterix Human Cancer Trial Advancing To Second Patient 1 PDF
14/10/2014 asterix Appendix 4C Quarterly & Company Update 6 PDF
02/10/2014 asterix Clinical Trial in Dogs is now open for accrual 1 PDF
23/09/2014   Notice of Annual General Meeting/Proxy Form 20 PDF
23/09/2014   Annual Report 60 PDF
09/09/2014 asterix Initiation of Clinical Trial in Dogs 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
24 Oct 2014 0.010 11.11% 0.011 0.009 7,128,415
23 Oct 2014 0.009 0% 0.009 0.009 5,100,000
22 Oct 2014 0.009 0% 0.009 0.009 2,889,075
21 Oct 2014 0.009 -10% 0.010 0.008 14,719,565
16 Oct 2014 0.010 0% 0.010 0.010 266,000

* Volume of shares shown represents only those shares traded on ASX.

PHARMAUST LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PAA. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PAA

Warrants & Structured Products

No warrants & Structured Products are available over the security PAA